Ophthalmic Steroid Drugs Market Driven by Eye Disease Incidence and Novel Formulations | Bausch & Lomb Inc., Alimera Sciences, Allergan, Inc., Novartis AG, GlaxoSmithKline plc

The global Ophthalmic Steroids Drugs Market size was valued USD 38.73 billion in 2024, and is estimated to reach USD 65.38 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025-2033).

Ophthalmic Steroids Drugs Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With demand for effective postsurgical inflammation control, advancements in nanoparticle-based formulations, and evolving regulatory approvals, the report delivers strategic insights for stakeholders in ophthalmic care from 2025 to 2033.

In the United States, Harrow recently acquired exclusive commercial rights to clobetasol propionate ophthalmic suspension (BYQLOVI) FDA-approved in March 2024, for the relief of post-ocular surgery pain and inflammation, with launch planned for Q4 2025. Additionally, the FDA approved prednisolone acetate ophthalmic suspension (1%) in mid-2025 as a self-administered eye drop to treat steroid-responsive ocular inflammation, with rollout expected in Q3-Q4 2025

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/ophthalmic-steroids-drugs-market?ophp

Ophthalmic steroid drugs are used to reduce inflammation in eye conditions such as uveitis, post-surgical swelling, and allergic conjunctivitis. The market is driven by increasing ophthalmic disease prevalence, aging populations, and new sustained-release formulations.

Ophthalmic Steroids Drugs Market Competitors Overview:

Bausch & Lomb Inc., Alimera Sciences, Allergan, Inc., Novartis AG, GlaxoSmithKline plc, Genentech, Inc., Pfizer Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. Shanghai Pharmaceutical Group Co., Ltd., China Res

Important Industry Updates:

On June 11, 2020, Novartis announced that the US Food and Drug Administration (FDA) had approved a label update for Beovu® (brolucizumab) to include additional safety information regarding retinal vasculitis and retinal vascular occlusion.

Methodology and Scope

The Ophthalmic Steroids Drugs Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/ophthalmic-steroids-drugs-market?ophp

Ophthalmic Steroids Drugs Market Segments Overview:

By Disease (Retinal Disorders, Eye Allergy, Uveitis, Others), By Dosage Form (Eye Drops, Eye Solutions, Ointments), By Distribution Channel (Hospital pharmacies, Online pharmacies, Clinics)

Regional Overview for Ophthalmic Steroids Drugs Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=ophthalmic-steroids-drugs-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Ophthalmic Steroids Drugs market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Ophthalmic Steroids Drugs market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.